2m 2m 2m 2m 2m 2m 2m
iShs Biotechnology (IBB)
NASDAQ
$201.38-$3.22 (-1.57%)
Price as of Sep 15, 2026 10:18 AM EDT- 45.76%1-Year Change
iShs Biotechnology (IBB)
$201.38-$3.22 (-1.57%)
- 233Holdings Count
- $10.3BTotal Assets
- 47.53%Top 10 Percentage
Holdings
Holding | Latest Close | Shares Held | Weight %
| Market Value |
|---|---|---|---|---|
VRTXVertex Pharma | $519.51 | 1.6M | 7.95% | $823.4M |
AMGNAmgen | $381.50 | 2.1M | 7.73% | $801.0M |
GILDGilead Sciences | $145.59 | 5.3M | 7.38% | $764.4M |
REGNRegeneron Pharma | $793.74 | 772,717 | 5.83% | $603.9M |
MRNAMODERNA | $146.69 | 2.8M | 3.87% | $400.6M |
ARGXarGEN-X SpADR | $990.54 | 397,871 | 3.78% | $391.7M |
NTRANatera | $341.79 | 1.0M | 3.32% | $344.0M |
$205.11 | 1.5M | 2.87% | $297.1M | |
ALNYAlnylam Pharma | $249.99 | 1.0M | 2.44% | $253.2M |
BIIBBiogen | $217.36 | 1.1M | 2.35% | $243.4M |
ILMNIllumina | $208.21 | 1.2M | 2.30% | $238.6M |
INSMInsmed | $125.30 | 1.6M | 2.05% | $212.7M |
ONCBeOne Medi Sp ADR | $353.83 | 609,674 | 2.04% | $211.3M |
INCYIncyte | $122.19 | 1.5M | 1.78% | $184.1M |
ROIVROIVANT SCIENCES | $41.02 | 4.0M | 1.56% | $161.4M |
$502.70 | 314,256 | 1.51% | $156.2M | |
GMABGENMAB SP ADR | $32.65 | 4.0M | 1.25% | $129.9M |
ASNDAscendis Pharma Br | $264.92 | 473,473 | 1.20% | $124.8M |
NBIXNeurocrine Biosc | $157.22 | 756,503 | 1.14% | $118.2M |
EXELExelixis | $56.21 | 1.9M | 1.01% | $104.7M |
MEDPMedpace Holdings | $595.41 | 176,187 | 1.00% | $103.5M |
CRLCharles Riv Lab | $273.11 | 364,455 | 0.98% | $101.4M |
HALOHalozyme Therape | $107.94 | 898,950 | 0.93% | $96.4M |
BMRNBiomarin Pharm | $66.41 | 1.5M | 0.92% | $95.7M |
BBIOBRIDGEBIO PHARMA | $72.38 | 1.3M | 0.91% | $93.8M |
MDGLMadrigal Pharmct | $540.06 | 166,130 | 0.86% | $88.8M |
$72.27 | 1.2M | 0.83% | $86.2M | |
ARWRArrowhead Phrmct | $80.67 | 1.0M | 0.81% | $84.0M |
CYTKCytokinetics | $72.45 | 1.0M | 0.73% | $75.4M |
AXSMAxsome Therapeut | $216.58 | 329,351 | 0.70% | $72.7M |
Holdings by Sector
- Healthcare100.00%